Protai
Signal active
Organization
Contact Information
Overview
Protai empowers drug discovery with proteomics and artificial intelligence to unlock new layers of biological insights and to combat complex diseases. Protai's platform has made a leap in solving how drug candidates are created and validated, facilitating quicker and more advanced drug discovery.
About
Industries
Biotechnology, Artificial Intelligence (AI), Life Science
Founded
2021
Employees
11-50
Headquarters locations
Asia
Social
N/A
Profile Resume
Protai headquartered in Asia, operates in the Biotechnology, Artificial Intelligence (AI), Life Science sector. The company focuses on Biotechnology and has secured $480.0M in funding across 24 round(s). With a team of 11-50 employees, Protai is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Protai, raised $12.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
3
Lead Investors
0
Total Funding Amount
$20.0M
Details
2
Protai has raised a total of $20.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Seed | 8.0M | ||
| 2023 | Seed | 12.0M |
Investors
Protai is funded by 13 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Maj Invest Equity | - | FUNDING ROUND - Maj Invest Equity | 12.0M |
| Ittai Harel | - | FUNDING ROUND - Ittai Harel | 12.0M |
| Protai | - | FUNDING ROUND - Protai | 12.0M |
| Pitango VC | - | FUNDING ROUND - Pitango VC | 12.0M |
Recent Activity
There is no recent news or activity for this profile.